FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Clementina Galluzzo

Research Profile

Living Beings

HIV-1

Disorders

Chemicals & Drugs

Procedures

Physiology

Concepts & Ideas

Viral Load

Co-author Network

Publications

TOP 3
Silvia Baroncelli; Andrea Cara; Oscar Cirioni; Alessandra Fantauzzi; Rina Fidanza; Vincenzo Fragola; Daniela Francisci; Clementina M Galluzzo; Nicoletta Ladisa; Ivano Mezzaroma; Laura Sighinolfi; Angela Vivarelli; Vincenzo Vullo; Liliana E Weimer; Anna Degli Antoni; Lucia Palmisano
No evidence of autoimmune disorders in antiretroviral-experienced HIV-1-infected individuals after long-term treatment with raltegravir.
Clementina M Galluzzo; Roberta Amici; Mauro Andreotti; Susanna Ceffa; Fulvio Erba; Haswell Jere; Giuseppe Liotta; Richard Luhanga; Sandro Mancinelli; Maria Cristina Marazzi; Martin Maulidi; leonardo Palombi; Maria F Pirillo; Jean-Baptiste Sagno; Stefano Vella; Marina Giuliano
Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi.
Raffaella Bucciardini; G Ceccarelli; O Cirioni; A Degli Antoni; Gabriella d'Ettorre; Marco Floridia; Vincenzo Fragola; Daniela Francisci; Clementina M Galluzzo; G Guaraldi; Nicoletta Ladisa; S Lucattini; P E Manconi; Giustino Parruti; Maria F Pirillo; R Preziosi; G Verucchi; V Vullo; Liliana E Weimer; Silvia Baroncelli; Rita Bellagamba
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Clementina Galluzzo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Silvia Baroncelli; Andrea Cara; Oscar Cirioni; Alessandra Fantauzzi; Rina Fidanza; Vincenzo Fragola; Daniela Francisci; Clementina M Galluzzo; Nicoletta Ladisa; Ivano Mezzaroma; Laura Sighinolfi; Angela Vivarelli; Vincenzo Vullo; Liliana E Weimer; Anna Degli Antoni; Lucia Palmisano
No evidence of autoimmune disorders in antiretroviral-experienced HIV-1-infected individuals after long-term treatment with raltegravir.
Antiviral therapy 2013;18(3):321-7.
2012: Clementina M Galluzzo; Roberta Amici; Mauro Andreotti; Susanna Ceffa; Fulvio Erba; Haswell Jere; Giuseppe Liotta; Richard Luhanga; Sandro Mancinelli; Maria Cristina Marazzi; Martin Maulidi; leonardo Palombi; Maria F Pirillo; Jean-Baptiste Sagno; Stefano Vella; Marina Giuliano
Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi.
Journal of medical virology 2012;84(10):1553-7.
2012: Raffaella Bucciardini; G Ceccarelli; O Cirioni; A Degli Antoni; Gabriella d'Ettorre; Marco Floridia; Vincenzo Fragola; Daniela Francisci; Clementina M Galluzzo; G Guaraldi; Nicoletta Ladisa; S Lucattini; P E Manconi; Giustino Parruti; Maria F Pirillo; R Preziosi; G Verucchi; V Vullo; Liliana E Weimer; Silvia Baroncelli; Rita Bellagamba
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors.
International journal of STD & AIDS 2012;23(7):459-63.
2012: Silvia Baroncelli; Raffaella Bucciardini; Albertina Cavalli; Anna Degli Antoni; Vincenzo Fragola; Daniela Francisci; Clementina M Galluzzo; Nicoletta Ladisa; Alessandra Mercuri; Laura Monno; Maria F Pirillo; Anna Volpe; Liliana E Weimer; Marco Floridia
Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.
The Journal of antimicrobial chemotherapy 2012;67(6):1479-85.
2012: leonardo Palombi; Simona Pichini; Maria F Pirillo; Jean-Baptiste Sagno; Stefano Vella; Mauro Andreotti; Susanna Ceffa; Fulvio Erba; Clementina M Galluzzo; Haswell Jere; Giuseppe Liotta; Maria Cristina Marazzi; Emilia Marchei; Martin Maulidi; Marina Giuliano
Antiretroviral prophylaxis for breastfeeding transmission in Malawi: drug concentrations, virological efficacy and safety.
Antiviral therapy 2012;17(8):1511-9.
2010: Zuleika Michelini; Clementina M Galluzzo; Donatella R M Negri; Pasqualina Leone; Roberta Amici; Roberta Bona; Vincenzo Summa; Roberto Di Santo; Roberta Costi; Yves Pommier; Christophe Marchand; Lucia Palmisano; Stefano Vella; Andrea Cara
Evaluation of HIV-1 integrase inhibitors on human primary macrophages using a luciferase-based single-cycle phenotypic assay.
Journal of virological methods 2010;168(1-2):272-6.
2010: Maria F Pirillo; Lucia Palmisano; Manuela Pellegrini; Clementina M Galluzzo; Liliana E Weimer; Raffaella Bucciardini; Vincenzo Fragola; Mauro Andreotti; Emilia Marchei; Simona Pichini; STEFANO VELLA; Marina Giuliano
Nonnucleoside reverse transcriptase inhibitor concentrations during treatment interruptions and the emergence of resistance: a substudy of the ISS-PART Trial.
AIDS research and human retroviruses 2010;26(5):541-5.
2009: Lucia Palmisano; Marina Giuliano; Clementina M Galluzzo; Roberta Amici; Mauro Andreotti; Liliana E Weimer; Maria F Pirillo; Vincenzo Fragola; Raffaella Bucciardini; STEFANO VELLA
The mutational archive in proviral DNA does not change during 24 months of continuous or intermittent highly active antiretroviral therapy.
HIV medicine 2009;10(8):477-81.
2009: Mauro Andreotti; Clementina M Galluzzo; Giovanni Guidotti; Paola Germano; Annamaria Doro Altan; Maria F Pirillo; Maria Cristina Marazzi; STEFANO VELLA; leonardo Palombi; Marina Giuliano
Comparison of HIV type 1 sequences from plasma, cell-free breast milk, and cell-associated breast milk viral populations in treated and untreated women in Mozambique.
AIDS research and human retroviruses 2009;25(7):707-11.
2009: Lucia Palmisano; Clementina M Galluzzo; Marina Giuliano
The importance of testing genotypic resistance in proviral DNA of patients fully responding to highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2009;51(2):233-4.
2008: Silvia Baroncelli; Paola Villani; Marco Floridia; Maria F Pirillo; Clementina M Galluzzo; Maria Cusato; Roberta Amici; Carmela Pinnetti; Francesca Sabbatini; Atim Molinari; Enrica Tamburrini; Mario Regazzi
Trough concentrations of lopinavir, nelfinavir, and nevirapine with standard dosing in human immunodeficiency virus-infected pregnant women receiving 3-drug combination regimens.
Therapeutic drug monitoring 2008;30(5):604-10.
2008: Roberto Di Santo; Roberta Costi; Alessandra Roux; Gaetano Miele; Giuliana Cuzzucoli Crucitti; Alberto Iacovo; Federica Rosi; Antonio Lavecchia; Luciana Marinelli; Carmen Di Giovanni; Ettore Novellino; Lucia Palmisano; Mauro Andreotti; Roberta Amici; Clementina M Galluzzo; Lucia Nencioni; Anna Teresa Palamara; Yves Pommier; Christophe Marchand
Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, and biological activities.
Journal of medicinal chemistry 2008;51(15):4744-50.
2007: Mauro Andreotti; Giovanni Guidotti; Clementina M Galluzzo; Sandro Mancinelli; Paola Germano; Maria F Pirillo; Maria Cristina Marazzi; STEFANO VELLA; leonardo Palombi; Marina Giuliano
Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention.
AIDS (London, England) 2007;21(17):2360-2.
2007: Clementina M Galluzzo; Elena A P Germinario; Luciana Bassani; Maria Grazia Mancini; Pius Okong; Joseph Vyankandondera; STEFANO VELLA; Marina Giuliano
Antiretroviral resistance mutations in untreated pregnant women with HIV infection in Uganda and Rwanda.
AIDS research and human retroviruses 2007;23(11):1449-51.
2007: Lucia Palmisano; Marina Giuliano; Raffaella Bucciardini; Vincenzo Fragola; Mauro Andreotti; Clementina M Galluzzo; Maria F Pirillo; Liliana E Weimer; Romano Arcieri; Elena A P Germinario; Roberta Amici; Maria Grazia Mancini; Antonella d'Arminio Monforte; Francesco Castelli; Pietro Caramello; STEFANO VELLA
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed Antiretroviral Therapy (ISS-PART) study.
Journal of acquired immune deficiency syndromes (1999) 2007;46(1):39-47.
2007: Maurizio Cianfriglia; Maria Luisa Dupuis; Agnese Molinari; Antonio Verdoliva ; Roberta Costi; Clementina M Galluzzo; Mauro Andreotti; Andrea Cara; Roberto Di Santo; Lucia Palmisano
HIV-1 integrase inhibitors are substrates for the multidrug transporter MDR1-P-glycoprotein.
Retrovirology 2007;4():17.
2006: Roberta Bona; Mauro Andreotti; Viviana Buffa; Pasqualina Leone; Clementina M Galluzzo; Roberta Amici; Lucia Palmisano; Maria Grazia Mancini; Zuleika Michelini; Roberto Di Santo; Roberta Costi; Alessandra Roux; Yves Pommier; Christophe Marchand; STEFANO VELLA; Andrea Cara
Development of a human immunodeficiency virus vector-based, single-cycle assay for evaluation of anti-integrase compounds.
Antimicrobial agents and chemotherapy 2006;50(10):3407-17.
2006: Marina Giuliano; Clementina M Galluzzo; Elena A P Germinario; Roberta Amici; Luciana Bassani; Lorenzo Dehò; Joseph Vyankandondera; Francis Mmiro; Pius Okong; STEFANO VELLA
Selection of resistance mutations in children receiving prophylaxis with lamivudine or nevirapine for the prevention of postnatal transmission of HIV.
Journal of acquired immune deficiency syndromes (1999) 2006;42(1):131-3.
2006: Roberto Di Santo; Roberta Costi; Alessandra Roux; Marino Artico; Antonio Lavecchia; Luciana Marinelli; Ettore Novellino; Lucia Palmisano; Mauro Andreotti; Roberta Amici; Clementina M Galluzzo; Lucia Nencioni; Anna Teresa Palamara; Yves Pommier; Christophe Marchand
Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action.
Journal of medicinal chemistry 2006;49(6):1939-45.
2005: Lucia Palmisano; Marina Giuliano; Emanuele Nicastri; Maria F Pirillo; Mauro Andreotti; Clementina M Galluzzo; Raffaella Bucciardini; Vincenzo Fragola; Massimo Andreoni; STEFANO VELLA
Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml: the impact of highly active antiretroviral therapy.
AIDS (London, England) 2005;19(16):1843-7.
2004: Emanuele Nicastri; Loredana Sarmati; Gabriella d'Ettorre; Saverio G Parisi; Lucia Palmisano; Marco Montano; Anna Rita Buonomini; Clementina M Galluzzo; Vincenzo Vullo; Ercole Concia; STEFANO VELLA; Massimo Andreoni
Non-B HIV type 1 subtypes: replicative capacity and response to antiretroviral therapy.
AIDS research and human retroviruses 2004;20(8):816-8.
2004: Marco Floridia; Raffaella Bucciardini; Vincenzo Fragola; Clementina M Galluzzo; Giacomo Giannini; Maria F Pirillo; Roberta Amici; Mauro Andreotti; D Ricciardulli; C Tomino; STEFANO VELLA
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL).
HIV medicine 2004;5(1):1-10.
2003: Marina Giuliano; Lucia Palmisano; Clementina M Galluzzo; Roberta Amici; Elena Germinario; Pius Okong; Praxedes Kituuka; Francis Mmirro; Michele Magoni; STEFANO VELLA
Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission.
AIDS (London, England) 2003;17(10):1570-2.
2003: Emanuele Nicastri; Loredana Sarmati; Gabriella d'Ettorre; Saverio G Parisi; Lucia Palmisano; Clementina M Galluzzo; Marco Montano; Ilaria Uccella; Roberta Amici; Francesca Gatti; Vincenzo Vullo; Ercole Concia; STEFANO VELLA; Massimo Andreoni
High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis.
Journal of clinical microbiology 2003;41(7):3007-12.
2003: Loredana Sarmati; Emanuele Nicastri; Ilaria Uccella; Gabriella d'Ettorre; Saverio G Parisi; Lucia Palmisano; Clementina M Galluzzo; Ercole Concia; Vincenzo Vullo; STEFANO VELLA; Massimo Andreoni
Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing.
Journal of clinical microbiology 2003;41(4):1760-2.
2002: Gabriella d'Ettorre; Gabriele Forcina; Mauro Andreotti; Loredana Sarmati; Lucia Palmisano; Clementina M Galluzzo; Emanuele Nicastri; Claudio M Mastroianni; Vincenzo Vullo; STEFANO VELLA; Massimo Andreoni
Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations, T-cell proliferation and cytokine production.
AIDS (London, England) 2002;16(14):1877-85.
2002: Marco Floridia; Vincenzo Fragola; Clementina M Galluzzo; Giacomo Giannini; Maria F Pirillo; Mauro Andreotti; C Tomino; STEFANO VELLA
HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/microL): an analysis of 338 clinical events from a randomized clinical trial.
HIV medicine 2002;3(2):75-84.
2000: Marco Floridia; C Tomino; Raffaella Bucciardini; D Ricciardulli; Vincenzo Fragola; Maria F Pirillo; Roberta Amici; Giacomo Giannini; Clementina M Galluzzo; Mauro Andreotti; AC Seeber; Adriana Ammassari; A Cingolani; Adriano Lazzarin; G Scalise; Antonietta Cargnel; Fredy Suter; F Milazzo; G Pastore; Mauro Moroni; R Ciammarughi; R Pini; Giampiero Carosi; C D'Amato; L Contu; Ercole Concia; L Bonazzi; Fernando Aiuti; Gianmarco Vigevani; STEFANO VELLA
A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection.
AIDS research and human retroviruses 2000;16(17):1809-20.
2000: Raffaella Bucciardini; Albert W Wu; Marco Floridia; Vincenzo Fragola; D Ricciardulli; C Tomino; Liliana E Weimer; Maria F Pirillo; Marco Mirra; MAURO MARZI; Giacomo Giannini; Clementina M Galluzzo; Mauro Andreotti; Maurizio Massella; STEFANO VELLA
Quality of life outcomes of combination zidovudine- didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients.
AIDS (London, England) 2000;14(16):2567-74.
2000: Marco Floridia; Maurizio Massella; Raffaella Bucciardini; C A Perucci; L Rossi; C Tomino; Vincenzo Fragola; D Ricciardulli; Clementina M Galluzzo; Giacomo Giannini; Maria F Pirillo; Mauro Andreotti; Marco Mirra; STEFANO VELLA
Hospitalizations and costs of treatment for protease inhibitor-based regimens in patients with very advanced HIV-infection (CD4 < 50/mm(3)).
HIV clinical trials 2000;1(2):9-16.
1999: Marco Floridia; Raffaella Bucciardini; D Ricciardulli; Vincenzo Fragola; Maria F Pirillo; Liliana E Weimer; C Tomino; Giacomo Giannini; Clementina M Galluzzo; Mauro Andreotti; Antonietta Cargnel; Francesco Alberici; B De Rienzo; Francesco Leoncini; F Fiaccadori; Daniela Francisci; W Grillone; L Ortona; M Piazza; A Scalzini; E Nigra; F Tumietto; STEFANO VELLA
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1999;20(1):11-9.
1998: Massimo Andreoni; Loredana Sarmati; Emanuele Nicastri; L Ventura; Lucia Ercoli; Saverio G Parisi; Giacomo Giannini; Clementina M Galluzzo; STEFANO VELLA
Saquinavir delays the emergence of zidovudine resistance in HIV-1 seropositive patients treated with combination therapy.
Journal of medical virology 1998;56(4):332-6.
1997: Lucia Ercoli; Loredana Sarmati; Emanuele Nicastri; Giacomo Giannini; Clementina M Galluzzo; STEFANO VELLA; Massimo Andreoni
HIV phenotype switching during antiretroviral therapy: emergence of saquinavir-resistant strains with less cytopathogenicity.
AIDS (London, England) 1997;11(10):1211-7.
1997: Massimo Andreoni; Loredana Sarmati; Lucia Ercoli; Emanuele Nicastri; Giacomo Giannini; Clementina M Galluzzo; Maria F Pirillo; STEFANO VELLA
Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy.
AIDS research and human retroviruses 1997;13(7):555-61.
1996: STEFANO VELLA; Clementina M Galluzzo; Giacomo Giannini; Maria F Pirillo; I Duncan; H Jacobsen; Massimo Andreoni; Loredana Sarmati; Lucia Ercoli
Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity.
Antiviral research 1996;29(1):91-3.
1995: Lucia Ercoli; Loredana Sarmati; Gamal El Sawaf; S Cochi; T Lanti; P Iudicone; M Guglielmetti; Giacomo Giannini; Clementina M Galluzzo; C Tomino
Plasma viremia titration and RNA quantitation in ICD-p24 negative HIV type-1-infected patients.
AIDS research and human retroviruses 1995;11(10):1203-7.
1994: Loredana Sarmati; Lucia Ercoli; Saverio G Parisi; Giovanni Rocchi; Giacomo Giannini; Clementina M Galluzzo; STEFANO VELLA; Massimo Andreoni
High rate of HIV isolation from plasma of asymptomatic patients through polyethylene glycol (PEG) treatment.
Journal of acquired immune deficiency syndromes 1994;7(1):10-4.